// App-Quantinova.ai

1074 : Glyco‐engineering and IgG‐Fc mutations to improve efficacy of monoclonal antibody therapy for breast cancer

Researchers

Presenter

  • Chenoweth A

Principal Investigators

  • Ilieva K

  • Cheung A

  • Marlow R

  • Grigoriadis A

  • Tutt A

  • Karagiannis S

Medical Centers

  • Kings College London, London, United Kingdom

  • Institute for Cancer Research, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Natural Killer cells

  • erb-b2 receptor tyrosine kinase 2

  • Immunoglobulin G

Drug/Treatment

  • Trastuzumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved